Circulating VE-cadherin in patients with controlled chronic lymphocytic leukemia
Aim. To evaluate the prognostic value of circulating VE-cadherin for cumulative survival in asymptomatic coronary artery disease patients with full or partial remission of limphoproliferative diseases. Methods. One hundred twelve patients with full or partial remission of chronic lymphocytic leukemi...
Saved in:
Main Author: | 10.1473 2310-1237.2014.2.28551 (Author) |
---|---|
Format: | Book |
Published: |
Zaporozhye State Medical University,
2014-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Circulating microparticles and thrombin generation in patients with Chronic Lymphocytic Leukemia
by: Fernanda Cristina Gontijo Evangelista, et al.
Published: (2022) -
Circulating proangiogenic cytokines and angiogenesis inhibitor endostatin in untreated patients with chronic lymphocytic leukemia
by: Joanna Gora-Tybor, et al.
Published: (2003) -
Chronic Lymphocytic Leukemia
Published: (2012) -
Occurrence of chronic lymphocytic leukemia in patients with chronic myelogenous leukemia
by: Pritish K Bhattacharyya
Published: (2013) -
Immunogenetics of chronic lymphocytic leukemia
by: Nikhil Patkar, et al.
Published: (2017)